Cargando…
Necrotising fasciitis in a patient treated with FOLFIRI-aflibercept for colorectal cancer: a case report
Anti-angiogenics have become an important part of the treatment of several types of tumours such as ovarian, breast, lung and colorectal cancer. Necrotising fasciitis has been reported with bevacizumab but no cases have been reported with aflibercept, ramucirumab or regorafenib in patients with colo...
Autores principales: | Gonzaga-López, A, Muñoz-Rodriguez, J, Ruiz-Casado, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Surgeons
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696931/ https://www.ncbi.nlm.nih.gov/pubmed/28768426 http://dx.doi.org/10.1308/rcsann.2017.0143 |
Ejemplares similares
-
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer
por: Carola, Candice, et al.
Publicado: (2018) -
Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report
por: Smyth, Andrew, et al.
Publicado: (2010) -
Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure
por: Aggarwal, Shyam
Publicado: (2015) -
Post-varicella Necrotising Fasciitis
por: Wiwanitkit, Viroj
Publicado: (2017) -
Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
por: Joulain, F, et al.
Publicado: (2013)